Design Therapeutics (DSGN) Equity Ratio: 2020-2021
Historic Equity Ratio for Design Therapeutics (DSGN) over the last 1 years, with Sep 2021 value amounting to 0.98.
- Design Therapeutics' Equity Ratio was N/A to 0.98 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.98, marking a year-over-year change of. This contributed to the annual value of -0.31 for FY2020, which is N/A change from last year.
- Per Design Therapeutics' latest filing, its Equity Ratio stood at 0.98 for Q3 2021, which was down 1.33% from 0.99 recorded in Q2 2021.
- Design Therapeutics' Equity Ratio's 5-year high stood at 0.99 during Q2 2021, with a 5-year trough of -0.31 in Q4 2020.
- Over the past 2 years, Design Therapeutics' median Equity Ratio value was 0.98 (recorded in 2021), while the average stood at 0.66.